Breaking News Instant updates and real-time market news.

BLCM

Bellicum Pharmaceuticals

$4.53

-0.05 (-1.09%)

16:08
11/06/18
11/06
16:08
11/06/18
16:08

Bellicum Pharmaceuticals reports Q3 EPS (55c), consensus (58c)

Reports Q3 revenue $292K, consensus $110K. As of September 30, 2018, cash, restricted cash and investments totaled $118.4 million. Based on current operating plans, Bellicum continues to expect that current cash resources will be sufficient to meet operating requirements through 2019.

  • 07

    Nov

  • 01

    Dec

BLCM Bellicum Pharmaceuticals
$4.53

-0.05 (-1.09%)

03/14/18
JEFF
03/14/18
NO CHANGE
Target $16
JEFF
Buy
Bellicum clinical hold should lift soon, says Jefferies
Jefferies analyst Biren Amin says Bellicum Pharmaceuticals last night provided an update of its leading prgm BPX-501 with an "encouraging" survival rate at one year in pediatric acute myeloid leukemia patients. For BPX-601, management reported CART cell expansion in one pancreatic cancer patient following rimiducid administration, providing first patient validation of the company's activation switch, Amin tells investors in a post-earnings research note. The analyst notes Bellicum has also responded to FDA including proposed protocol changes. Amin believes the clinical hold should lift soon and keeps a Buy rating on Bellicum Pharmaceuticals with a $16 price target.
04/11/18
WELS
04/11/18
UPGRADE
WELS
Outperform
Bellicum Pharmaceuticals upgraded to Outperform at Wells Fargo
04/12/18
WELS
04/12/18
UPGRADE
Target $23
WELS
Outperform
Wells Fargo upgrades Bellicum to Outperform on lifting of clinical hold
Wells Fargo analyst Jim Birchenough last night upgraded Bellicum Pharmaceuticals to Outperform from Market Perform and raised his price target for the shares to $23 from $6. The shares in premarket trading are up 27% to $8.70 following news that the FDA lifted the clinical hold on studies of BPX-501 in the U.S. Rapid resolution of the clinical hold "substantially de-risks the investment," Birchenough tells investors in a research note. He believes Bellicum's platform for controllable cell therapies is well positioned for therapeutic oncology indications.
04/12/18
CANT
04/12/18
NO CHANGE
Target $18
CANT
Overweight
Bellicum price target raised to $18 from $10 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Bellicum Pharmaceuticals to $18 following the announcement of the FDA's lift of its U.S. clinical hold for BPX-501. The analyst now has increased confidence across the BPX-501 platform. He reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

13:00
11/20/18
11/20
13:00
11/20/18
13:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

SPY

SPDR S&P 500 ETF Trust

$265.59

-3.69 (-1.37%)

, SPX

S&P 500

$0.00

(0.00%)

12:59
11/20/18
11/20
12:59
11/20/18
12:59
General news
Trump says Saudi Arabia remains 'steadfast partner,' may never know all facts »

In a statement that…

SPY

SPDR S&P 500 ETF Trust

$265.59

-3.69 (-1.37%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$41.82

-0.23 (-0.55%)

12:55
11/20/18
11/20
12:55
11/20/18
12:55
Options
Seagate put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

TJX

TJX

$47.05

-1.92 (-3.92%)

12:52
11/20/18
11/20
12:52
11/20/18
12:52
Recommendations
TJX analyst commentary  »

TJX labor, transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

ADI

Analog Devices

$89.07

3.52 (4.11%)

12:50
11/20/18
11/20
12:50
11/20/18
12:50
Upgrade
Analog Devices rating change  »

Analog Devices upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

EA

Electronic Arts

$82.95

-0.09 (-0.11%)

, MSFT

Microsoft

$102.65

-1.97 (-1.88%)

12:48
11/20/18
11/20
12:48
11/20/18
12:48
OnTheFly
Game On: Nintendo, Microsoft still committed to E3 as Sony plans to skip »

Welcome to "Game On," The…

EA

Electronic Arts

$82.95

-0.09 (-0.11%)

MSFT

Microsoft

$102.65

-1.97 (-1.88%)

SNE

Sony

$49.86

-1.12 (-2.20%)

NTDOY

Nintendo

$0.00

(0.00%)

ATVI

Activision Blizzard

$49.80

0.63 (1.28%)

T

AT&T

$29.79

-0.55 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

12:40
11/20/18
11/20
12:40
11/20/18
12:40
Options
Bearish spread in Invesco Senior Loan Portfolio as shares set 52-week lows »

Bearish spread in Invesco…

12:40
11/20/18
11/20
12:40
11/20/18
12:40
General news
Treasury Action: yields are mixed along the curve »

Treasury Action: yields…

NOK

Nokia

$5.58

-0.145 (-2.53%)

12:35
11/20/18
11/20
12:35
11/20/18
12:35
Options
Nokia put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$125.44

-0.82 (-0.65%)

12:27
11/20/18
11/20
12:27
11/20/18
12:27
Hot Stocks
Motorola Solutions wins second patent infringement suit against Hytera Mobilfunk »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Dec

  • 19

    Dec

CLF

Cleveland-Cliffs

$9.37

-0.6 (-6.02%)

12:25
11/20/18
11/20
12:25
11/20/18
12:25
Options
Cleveland-Cliffs call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMAC

MMA Capital

$26.50

-0.2 (-0.75%)

12:25
11/20/18
11/20
12:25
11/20/18
12:25
Conference/Events
MMA Capital to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SANW

S&W Seed

$3.05

(0.00%)

12:25
11/20/18
11/20
12:25
11/20/18
12:25
Conference/Events
S&W Seed to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

12:25
11/20/18
11/20
12:25
11/20/18
12:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

TGT

Target

$69.29

-7.84 (-10.16%)

, BBY

Best Buy

$64.05

1.86 (2.99%)

12:19
11/20/18
11/20
12:19
11/20/18
12:19
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

TGT

Target

$69.29

-7.84 (-10.16%)

BBY

Best Buy

$64.05

1.86 (2.99%)

CPB

Campbell Soup

$40.60

2.13 (5.54%)

KLIC

Kulicke & Soffa

$22.18

2.28 (11.46%)

A

Agilent

$67.54

4.97 (7.94%)

LIVN

LivaNova

$102.03

-18.25 (-15.17%)

LB

L Brands

$30.14

-4.39 (-12.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 27

    Nov

  • 05

    Dec

  • 11

    Dec

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/20/18
11/20
12:17
11/20/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/20/18
11/20
12:16
11/20/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$34.13

-1.16 (-3.29%)

12:10
11/20/18
11/20
12:10
11/20/18
12:10
Options
Puts lead calls 4:1 in Boston Scientific as implied volatilities lift »

Puts lead calls 4:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

12:10
11/20/18
11/20
12:10
11/20/18
12:10
General news
U.S. equities remain under pressure »

U.S. equities remain…

AMAT

Applied Materials

$36.27

1.85 (5.37%)

12:05
11/20/18
11/20
12:05
11/20/18
12:05
Options
Applied Materials call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
11/20/18
11/20
12:05
11/20/18
12:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

FB

Facebook

$133.04

1.42 (1.08%)

12:02
11/20/18
11/20
12:02
11/20/18
12:02
Hot Stocks
Facebook experiencing service issues »

Visiting Facebook.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

EGRX

Eagle Pharmaceuticals

$48.01

-1.36 (-2.75%)

12:01
11/20/18
11/20
12:01
11/20/18
12:01
Conference/Events
Eagle Pharmaceuticals management to meet with RBC Capital »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 02

    Dec

SDRL

Seadrill

$14.63

-1.84 (-11.17%)

12:00
11/20/18
11/20
12:00
11/20/18
12:00
Hot Stocks
Seadrill falls -11.2% »

Seadrill is down -11.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EROS

Eros International

$8.19

-1.16 (-12.41%)

12:00
11/20/18
11/20
12:00
11/20/18
12:00
Hot Stocks
Eros International falls -12.4% »

Eros International is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 20

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.